These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2905952)

  • 21. Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.
    Meller E
    Psychopharmacology (Berl); 1982; 76(3):222-7. PubMed ID: 6808540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrethroids: involvement of sodium channels in effects on inositol phosphate formation in guinea pig synaptoneurosomes.
    Gusovsky F; Secunda SI; Daly JW
    Brain Res; 1989 Jul; 492(1-2):72-8. PubMed ID: 2546657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
    Toide K; Unemi N; Segawa T
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain.
    Fernández-Ruiz JJ; de Miguel R; Hernández ML; Ramos JA
    Pharmacol Biochem Behav; 1990 Jul; 36(3):603-6. PubMed ID: 2377660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pyrethroids on lymphocyte membrane lipid packing order.
    Stelzer KJ; Gordon MA
    J Immunopharmacol; 1984; 6(4):389-410. PubMed ID: 6527010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postsynaptic receptors are not essential for dopaminergic feedback regulation.
    Di Chiara G; Porceddu ML; Fratta W; Gessa GL
    Nature; 1977 May; 267(5608):270-2. PubMed ID: 865621
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of chronic apomorphine on the development of denervation supersensitivity.
    Robin M; Forler C; Palfreyman MG
    Pharmacol Biochem Behav; 1985 Apr; 22(4):547-51. PubMed ID: 3921992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of effect of prolactin on the dopaminergic receptor sensitivity in striatal and limbic areas after experimentally-induced alterations in its peripheral levels.
    Cebeira M; Hernandez ML; Rodriguez de Fonseca F; de Miguel R; Fernandez-Ruiz JJ; Ramos JA
    Life Sci; 1991; 48(6):531-41. PubMed ID: 1671524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
    Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S
    Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivity to amphetamine in perinatally undernourished rats: behavioral and neurochemical correlates.
    Brioni JD; Keller EA; Levin LE; Córdoba N; Orsingher OA
    Pharmacol Biochem Behav; 1986 Mar; 24(3):449-54. PubMed ID: 3703881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
    Conway PG; Uretsky NJ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of type I and type II pyrethroids on the startle response in rats.
    Hijzen TH; Slangen JL
    Toxicol Lett; 1988 Feb; 40(2):141-52. PubMed ID: 3341055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotoxicological effects of a pyrethroid formulation, fenvalerate in rats.
    Husain R; Gupta A; Khanna VK; Seth PK
    Res Commun Chem Pathol Pharmacol; 1991 Jul; 73(1):111-4. PubMed ID: 1882120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
    Kelly E; Jenner P; Marsden CD
    J Pharm Pharmacol; 1987 Mar; 39(3):196-202. PubMed ID: 2883284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of cholecystokinin on dopaminergic mechanisms in rat striatum.
    Mashal RD; Owen F; Deakin JF; Poulter M
    Brain Res; 1983 Oct; 277(2):375-6. PubMed ID: 6315150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance to nicotine's effects on striatal dopamine metabolism in nicotine-withdrawn mice.
    Pietilä K; Salminen O; Leikola-Pelho T; Ahtee L
    Eur J Pharmacol; 1996 Dec; 318(1):17-22. PubMed ID: 9007507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E; Friedman E
    Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidences for a direct action in striatum of dopaminergic receptor antagonists mediating DOPAC formation.
    Racagni G; Groppetti A; Parenti M; Bugatti A; Bruno F; Maggi A; Cattabeni F
    Life Sci; 1978 Oct; 23(17-18):1757-61. PubMed ID: 723449
    [No Abstract]   [Full Text] [Related]  

  • 39. Stereospecific long-term effects of amphetamine on striatal dopamine neurons in rats.
    Steranka LR
    Eur J Pharmacol; 1981 Dec; 76(4):443-6. PubMed ID: 7327212
    [No Abstract]   [Full Text] [Related]  

  • 40. Behavioural effects of long-term administration of fencamfamine: neurochemical implications.
    Planeta CS; Scavone C; De Lucia R; Aizenstein ML
    Gen Pharmacol; 1987; 18(4):347-9. PubMed ID: 3609692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.